Healthy Skepticism Library item: 19144
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Sales Through Retail Pharmacies (Twelve months to December 2010)
IMS Health 2011 Feb
http://view.respond.imshealth.com/?j=fe5815787d6405747d10&m=fef31377726304&ls=fdfa17757666017475127374&l=fe9615727662037d73&s=fe21127975600c75701171&jb=ffcf14&ju=fe28167271610c7e711778&r=0
Full text:
NORTH AMERICA $243.8 billion up 3%
U.S.A. $224.5 billion up 3%
CANADA $19.3 billion up 3%
EUROPE (TOP 5) $106.1 billion up 1%
GERMANY $34.6 billion up 3%
FRANCE $27.9 billion up 0%
ITALY $15.7 billion up 0%
SPAIN $14.3 billion up 0%
UK $13.6 billion up 2%
JAPAN (including hospitals) $85.7 billion up 0%
CHINA (hospital) $32.2 billion up 23%
LATIN AMERICA (TOP 4) $35.6 billion
BRAZIL $17.5 billion up 20%
MEXICO $7.8 billion up 2%
VENEZUELA $6.2 billion up 32%
ARGENTINA $4.0 billion up 25%
AUSTRALIA/NZ $9.7 billion up 6%
The top 5 therapy classes at ATC3 level in the 12 months to December 2010 were:
1. C10A – Cholesterol & trigly. regulators Buy Forecast for USA Market
2. A2B – Antiulcerants Buy Forecast for China Market
3. N5A – Antipsychotics Buy Forecast for Italy Market
4. N6A – Antidepressants & mood stabilisers Buy Forecast for UK Market
5. C9C – Angioten-II Antag, Plain Buy Forecast for Germany Market
The top 5 products in the 12 months to December 2010 were:
1. Lipitor
2. Plavix
3. Nexium
4. Seretide
5. Crestor
The top 5 corporations in the 12 months to December 2010 were:
1. Pfizer
2. Novartis
3. AstraZeneca
4. Merck & Co
5. GlaxoSmithKline
View our full selection of Pharma Market Sales and Growth Reports in the IMS Store here: http://www.store.imshealth.com/s.nl/sc.1/category.10/.f
*Source: IMS HEALTH. Growth rates are calculated at a constant exchange rate, (i.e. at the local currency level).The unique system in Japan reduces the importance of the retail pharmacy in the distribution chain so sales for Japan include hospital data. For the USA, retail, foodstore and mail order pharmacy channels are included. In other countries sales monitored are limited to retail pharmacies only.
